What is the 13F Pro Quality Score for A?

13F Pro ranks AGILENT TECHNOLOGIES, INC. (A) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View A's current score at https://13fpro.ai/company/A (free sign-up required for the full ranking).

Where does 13F Pro source A data?

All AGILENT TECHNOLOGIES, INC. fundamentals and ownership data come directly from SEC EDGAR. AGILENT TECHNOLOGIES, INC. files with the SEC under CIK 1090872. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

AGILENT TECHNOLOGIES, INC. (A) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

What drives A's revenue?

Per AGILENT TECHNOLOGIES, INC.'s latest 10-Q filed with the SEC on 2026-09-01, the biggest revenue drivers are: Agilent CrossLab ($786M, +6% YoY); Life Sciences and Diagnostics Markets ($746M, +11% YoY); Applied Markets ($346M, +7% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/A.

How often is A research updated on 13F Pro?

A's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

AGILENT TECHNOLOGIES, INC.(A)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →NYSElarge

Institutional-grade research for retail investors

SEC EDGAR: CIK 1090872 A stock profile & AI dashboard →

13F Pro Quality Score

67.1/100

Rank #378 of 2,961 stocksTOP 25%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

49.0/100

Profitability

80.6/100

Balance Sheet

87.4/100

Earnings Quality

43.9/100

Free Cash Flow

68.7/100

Institutional Flow

74.9/100

Revenue Scale

83.1/100

Dilution Risk

41.5/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why A Scores 67/100

exact factor attribution · 2026-09-11

A's composite is driven by scale and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+5.0 pts

83th pct

Profitability

+4.6 pts

81th pct

Capital efficiency

+3.7 pts

87th pct

Free cash flow

+2.8 pts

69th pct

Institutional flow

+1.3 pts

75th pct

Earnings growth

+1.0 pts

70th pct

Revenue growth

-0.2 pts

49th pct

Shareholder dilution

-0.4 pts

42th pct

Earnings quality

-0.6 pts

44th pct

Latest change (2026-09-01): 65 → 67 · ↑ Revenue growth 48→57; despite ↓ Earnings growth 46→35

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

A Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for AGILENT TECHNOLOGIES, INC. (A), a Technology sector company. 13F Pro's AI-powered ranking engine scores A at 67.1/100 on a 32-signal composite quality model, placing it at rank #378 of 2,961 stocks — the top 25% of the AI-ranked universe. A scores in the top quartile across balance sheet strength (87.4), revenue scale (83.1), profitability (80.6). Shareholder dilution risk is elevated at 41.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AGILENT TECHNOLOGIES, INC. reports quarterly revenue of $1.9B, net income of $362.0M, an operating margin of 23.6%. Top institutional holders of A by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. A trades on the NYSE exchange and files with the SEC under CIK 1090872. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate A daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AGILENT TECHNOLOGIES, INC. directly from SEC EDGAR. AGILENT TECHNOLOGIES, INC.'s 13F Pro composite quality score has ranged between 62 and 74 since 2021, currently 67.1 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.

What's Driving A's Business? Latest 10-Q Breakdown

✓ 24/24 datapoints verified

AI-extracted from AGILENT TECHNOLOGIES, INC.'s 10-Q filed 2026-09-01 — Q3 FY2026 (quarter ended July 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Agilent reported Q3 revenue of $1.88B (+8% YoY) with net income of $362M, while acquiring Biocare for $950M to expand its pathology portfolio.

Biggest Revenue Drivers

Agilent CrossLab$786M+6% YoY

Services and consumables portfolio; strong growth in repair, maintenance, compliance services and consumables businesses across pharmaceutical and chemical markets.

Life Sciences and Diagnostics Markets$746M+11% YoY

Strong revenue growth from liquid chromatography, Agilent Advanced Therapeutics, consumables and genomics businesses; includes Biocare acquisition contribution.

Biggest Revenue Drivers

Total revenue: $1,878M+8% YoY

Agilent CrossLab$786M+6% YoY

Services and consumables portfolio; strong growth in repair, maintenance, compliance services and consumables businesses across pharmaceutical and chemical markets.

Life Sciences and Diagnostics Markets$746M+11% YoY

Strong revenue growth from liquid chromatography, Agilent Advanced Therapeutics, consumables and genomics businesses; includes Biocare acquisition contribution.

Applied Markets$346M+7% YoY

Strong growth in chemical and advanced materials market driven by spectroscopy, gas chromatography, remarketed instruments and vacuum businesses.

Largest Expense Items

Cost of products and services$836M-1% YoY

Higher sales volume and tariff refunds offset by wage increases and higher variable pay.

Selling, general and administrative$475M+14% YoY

Higher costs from transformational initiatives, variable pay, wage increases and unfavorable currency impact.

Research and development$123M+10% YoY

Higher costs from transformational initiatives, wage increases and higher variable pay partially offset by restructuring savings.

Margins: Gross margin improved 4 percentage points to 55.5%, driven by higher sales volume, net tariff refunds, price increases and favorable mix, partially offset by wage and variable pay increases. Operating margin expanded 3 percentage points to 23.6%, benefiting from gross margin expansion and lower restructuring costs despite higher transformational initiative expenses.

Watch Items from the Filing

Biocare acquisition on June 24, 2026 for $950M net cash consideration adds $549M goodwill and $520M intangible assets, representing material integration risk and synergy execution dependency.
Tariff situation remains dynamic with only de minimis net benefit (~1 ppt margin lift) from IEEPA refunds; future refund timing and approval uncertain pending legal and regulatory developments.
Inventory days on hand increased to 120 days from 107 days YoY due to strategic tariff mitigation purchases, tying up $110M in cash flow YTD.
FY26 and FY25 restructuring plans total $124M cumulative expense with expected annual savings of $120M–$130M once completed; execution risk on realizing full benefit.
Academic and government market revenue declined; this end-market showed weakness across Life Sciences and Agilent CrossLab segments despite overall company growth.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$1.9B

Net Income

Q2 2026

$362.0M

Free Cash Flow

Q2 2026

$439.0M

Operating Margin

Q2 2026

23.6%

ROIC

Q2 2026

15.7%

D/E Ratio

Q2 2026

0.54

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+6.7% YoY

$6.95BFY 2025

FY22 $6.85BFY23 $6.83BFY24 $6.51BFY25 $6.95B

Net Income

+1.1% YoY

$1.30BFY 2025

FY22 $1.25BFY23 $1.24BFY24 $1.29BFY25 $1.30B

Operating Income

-0.6% YoY

$1.48BFY 2025

FY22 $1.62BFY23 $1.35BFY24 $1.49BFY25 $1.48B

EPS (Diluted)

+3.2% YoY

$4.57FY 2025

FY22 $4.18FY23 $4.19FY24 $4.43FY25 $4.57

Total Assets

+7.4% YoY

$12.73BFY 2025

FY22 $10.53BFY23 $10.76BFY24 $11.85BFY25 $12.73B

Total Debt

-1.1% YoY

$3.35BFY 2025

FY22 $2.77BFY23 $2.73BFY24 $3.39BFY25 $3.35B

Op. Cash Flow

-11.0% YoY

$1.56BFY 2025

FY22 $1.31BFY23 $1.77BFY24 $1.75BFY25 $1.56B

Free Cash Flow

-16.1% YoY

$1.15BFY 2025

FY22 $1.02BFY23 $1.47BFY24 $1.37BFY25 $1.15B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$6.95B +6.7%	$6.51B -4.7%	$6.83B -0.2%	$6.85B +8.4%	$6.32B +18.4%	$5.34B
Net Income	$1.30B +1.1%	$1.29B +4.0%	$1.24B -1.1%	$1.25B +3.6%	$1.21B +68.3%	$719.0M
Operating Income	$1.48B -0.6%	$1.49B +10.2%	$1.35B -16.6%	$1.62B +20.1%	$1.35B +59.2%	$846.0M
EPS (Diluted)	$4.57 +3.2%	$4.43 +5.7%	$4.19 +0.2%	$4.18 +6.1%	$3.94 +71.3%	$2.30
Total Assets	$12.73B +7.4%	$11.85B +10.1%	$10.76B +2.2%	$10.53B -1.6%	$10.71B +11.2%	$9.63B
Total Debt	$3.35B -1.1%	$3.39B +23.9%	$2.73B -1.2%	$2.77B +1.5%	$2.73B +15.7%	$2.36B
Operating Cash Flow	$1.56B -11.0%	$1.75B -1.2%	$1.77B +35.1%	$1.31B -11.6%	$1.49B +61.2%	$921.0M
Free Cash Flow	$1.15B -16.1%	$1.37B -6.9%	$1.47B +44.4%	$1.02B -21.3%	$1.30B +61.7%	$802.0M

Get alerted when A's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for AGILENT TECHNOLOGIES, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of A

BlackRock, Inc.
$3.4B25,599,001 sh
VANGUARD CAPITAL MANAGEMENT LLC
$2.5B18,449,861 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.9B14,442,441 sh
STATE STREET CORP
$1.7B12,854,230 sh
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$1.4B10,010,867 sh
T. Rowe Price Investment Management, Inc.
$1.0B7,756,921 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.0B7,595,644 sh
WELLINGTON MANAGEMENT GROUP LLP
$990.2M7,454,686 sh
DEUTSCHE BANK AG\
$931.0M7,008,634 sh
Bank of New York Mellon Corp
$695.2M5,233,964 sh

Fund	Value	Shares
BlackRock, Inc.	$3.4B	25,599,001
VANGUARD CAPITAL MANAGEMENT LLC	$2.5B	18,449,861
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.9B	14,442,441
STATE STREET CORP	$1.7B	12,854,230
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$1.4B	10,010,867
T. Rowe Price Investment Management, Inc.	$1.0B	7,756,921
GEODE CAPITAL MANAGEMENT, LLC	$1.0B	7,595,644
WELLINGTON MANAGEMENT GROUP LLP	$990.2M	7,454,686
DEUTSCHE BANK AG\	$931.0M	7,008,634
Bank of New York Mellon Corp	$695.2M	5,233,964

Companies Similar to A

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

KEYS

Keysight Technologies, Inc.

AI score

Very similar · 43 shared holders

T. Rowe Price Investment Management, Inc.PRIMECAP MANAGEMENT CO/CA/Findlay Park Partners LLP

VLTO

Veralto Corp

AI score

Very similar · 40 shared holders

T. Rowe Price Investment Management, Inc.Impax Asset Management Group plc Robeco Schweiz AG

AME

AMETEK INC/

AI score

Very similar · 28 shared holders

NORDEA INVESTMENT MANAGEMENT AB PRIMECAP MANAGEMENT CO/CA/VOLORIDGE INVESTMENT MANAGEMENT, LLC

MSI

Motorola Solutions, Inc.

AI score

Very similar · 25 shared holders

Alyeska Investment Group, L.P.NORDEA INVESTMENT MANAGEMENT AB National Pension Service

DHR

DANAHER CORP /DE/

AI score

Very similar · 27 shared holders

T. Rowe Price Investment Management, Inc.NORDEA INVESTMENT MANAGEMENT AB GLENVIEW CAPITAL MANAGEMENT, LLC

ROK

ROCKWELL AUTOMATION, INC

AI score

Very similar · 32 shared holders

NORDEA INVESTMENT MANAGEMENT AB PRIMECAP MANAGEMENT CO/CA/Candriam S.C.A.

TMO

THERMO FISHER SCIENTIFIC INC.

AI score

Very similar · 26 shared holders

GLENVIEW CAPITAL MANAGEMENT, LLC PRIMECAP MANAGEMENT CO/CA/Candriam S.C.A.

ADP

AUTOMATIC DATA PROCESSING INC

AI score

Very similar · 27 shared holders

STATE FARM MUTUAL AUTOMOBILE INSURANCE CO NORDEA INVESTMENT MANAGEMENT AB WORLDQUANT MILLENNIUM ADVISORS LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Technology Companies

View all Technology →

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

ACM

AECOM

Put A on your watchlist

Track score changes the day AGILENT TECHNOLOGIES, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is A a good stock to buy?

13F Pro's AI-powered analysis of AGILENT TECHNOLOGIES, INC. (A) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for A are available on the A stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. A is classified as a large company.

Which hedge funds own A?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling A. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AGILENT TECHNOLOGIES, INC.'s investment landscape.